| Literature DB >> 35869424 |
Esteban Fernández1, Shengjie Yang2, Sy Han Chiou1, Chul Moon3, Cong Zhang1, Bo Yao2, Guanghua Xiao4, Qiwei Li5.
Abstract
BACKGROUND: Recent developments to segment and characterize the regions of interest (ROI) within medical images have led to promising shape analysis studies. However, the procedures to analyze the ROI are arbitrary and vary by study. A tool to translate the ROI to analyzable shape representations and features is greatly needed.Entities:
Keywords: Machine learning; Medical imaging; Shape descriptors; Shape representations
Mesh:
Year: 2022 PMID: 35869424 PMCID: PMC9308199 DOI: 10.1186/s12880-022-00849-8
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 2.795
Fig. 1SAFARI package workflow: (1) whole-slide image is processed by an Automated Tumor Recognition System (ATRS) and converted into a binary format, (2) ROI are identified and segmentedfrom the input binary image, (3) shape features are simultaneously computed for the downstream analysis
Fig. 2SAFARI online analysis interface, instructions, and results page
Overview of the 29 shape features in three categories
| Category | Features |
|---|---|
| Geometric | Net area, thickness, elongation, filled area, perimeter, circularity, fibre length, fibre width, convex area, convex perimeter, roundness, convexity, solidity, major axis length, major axis angle, minor axis length, bounding box area, eccentricity, and curl |
| Boundary | Bending energy, total absolute curvature, radial mean, radial standard deviation, entropy, area ratio, zero crossing count, and normalized moment classifier |
| Topological | Number of holes and number of protrusions |
For a full table and a diagram, refer to Additional file 1: Table S3 and Fig. S3, respectively
Fig. 3Survival curves, estimated using the Kaplan-Meier method, for both high-risk and low-risk groups
Multivariable analysis of the predicted risk group
| Hazard Ratio (HR) with | ||
|---|---|---|
| High-risk versus low-risk | 2.32 (1.19–4.52) | |
| Age | 1.09 (1.03–1.16) | |
| Male versus female | 0.92 (0.49-1.74) | 0.7964 |
| Smoker versus non-smoker | 0.94 (0.51–1.72) | 0.8429 |
| Stage II versus stage I | 1.30 (0.44–3.88) | 0.6323 |
| Stage III versus stage I | 3.79 (1.93–7.45) | ≤ |
| Stage IV versus stage I | 4.26 (1.67–10.83) |
A Cox proportional-hazards (CoxPH) model was fitted to test the predictive performance of the predicted risk score, adjusted for clinical variables and based on the leave-one-out cross-validation results
*Bolding signifies features with p value ≤ 0.05.